Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer

Breast Cancer Research and Treatment

Volumn 121, Issue 1, 2010, Pages 35-40

  Gudlaugsson, Einar ^a,b   Skaland, Ivar ^a,b   Janssen, Emiel A M ^a   Van Diest, Paul J ^d   Voorhorst, Feja J ^e   Kjellevold, Kjell ^a   Hausen, Axel Zur ^f   Baak, Jan P A ^a,b,c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Lobular invasive breast cancer; Mitotic activity index; Prognosis; Proliferation

Indexed keywords

ESTROGEN RECEPTOR; UVOMORULIN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MITOSIS RATE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

AREA UNDER CURVE; BREAST NEOPLASMS; CARCINOMA, LOBULAR; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; NEOPLASM STAGING; PROGNOSIS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 77951297807     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0442-x     Document Type: Article

References (14)

1. Ellis IO, Schnitt SJ, Sastre-Garau X (2003) Invasive breast carcinoma. In: Tavassoli FA, Devilee P et al (eds) Pathology and genetics of tumours of the breast and female genital organs: WHO classification of tumours series. IARC press, Lyon, pp 13-48
2. MC Mathieu R Rouzier A Llombart-Cussac, et al. 2004 The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile Eur J Cancer 40 342 351 10.1016/j.ejca.2003.08.015 10.1016/j.ejca.2003.08.015 14746851 (Pubitemid 38121270)
3. V Cocquyt S Van Belle 2005 Lobular carcinoma in situ and invasive lobular cancer of the breast Curr Opin Obstet Gynecol 17 55 60 10.1097/00001703- 200502000-00010 15711412 (Pubitemid 40315265)
4. JM Dixon TJ Anderson DL Page, et al. 1982 Infiltrating lobular carcinoma of the breast Histopathology 6 149 161 10.1111/j.1365-2559.1982.tb02712.x 10.1111/j.1365-2559.1982.tb02712.x 1:STN:280:DyaL387ovVarsQ%3D%3D 7076138
5. G Arpino VJ Bardou GM Clark RM Elledge 2004 Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Breast Cancer Res 6 R149 R156 10.1186/bcr767 10.1186/bcr767 15084238
6. JS Reis-Filho PT Simpson C Jones D Steele A Mackay M Iravani, et al. 2005 Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity J Pathol 207 1 13 10.1002/path.1806 10.1002/path.1806 1:CAS:528:DC%2BD2MXhtVemtrzK 15957152 (Pubitemid 41200708)
7. JP Baak PJ van Diest FJ Voorhorst E van der Wall LV Beex JB Vermorken, et al. 2005 Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years J Clin Oncol 23 25 5993 6001 10.1200/JCO.2005.05.511 10.1200/JCO.2005.05.511 16135467 (Pubitemid 46300216)
8. JP Baak PJ van Diest EA Janssen, et al. 2008 Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers Ann Oncol 19 4 649 654 10.1093/annonc/mdm535 10.1093/annonc/mdm535 1:STN:280:DC%2BD1c3gsVOjug%3D%3D 18042836 (Pubitemid 351461033)
9. LM McShane DG Altman W Sauerbrei, et al. 2005 Reporting recommendations for tumor marker studies J Clin Oncol 23 36 9067 9072 10.1200/JCO.2004.01.0454 16172462 (Pubitemid 46260161)
10. JPA Baak W Snijders B van Diermen, et al. 2003 Prospective multicenter validation confirms the prognostic superiority of the ECPI in FIGO-1 endometrial carcinoma J Clin Oncol 23 4214 4221 10.1200/JCO.2003.02.087 10.1200/JCO.2003.02.087 (Pubitemid 46606191)
11. I Jannink JN Bennen J Blaauw, et al. 1995 At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients Breast Cancer Res Treat 36 55 60 10.1007/BF00690185 10.1007/BF00690185 1:STN:280:DyaK28%2FnsFyitA%3D%3D 7579507
12. JC Fleege PJ van Diest JPA Baak 1993 Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections. Refinement and multiobserver evaluation Anal Quant Cytol Histol 15 281 289 1:STN:280:DyaK2c%2FgtVWrtA%3D%3D 8397649
13. I Skaland PJ van Diest EAM Janssen, et al. 2008 Prognostic differences of WHO-assessed mitotic activity index (MAI) and mitotic impression by quick scanning in invasive ductal breast cancer patients under 55 years of age Hum Pathol 39 4 584 590 10.1016/j.humpath.2007.08.016 10.1016/j.humpath.2007.08.016 18291440
14. EA Rakha ME El-Sayed S Menon, et al. 2008 Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast Breast Cancer Res Treat 111 1 121 127 10.1007/s10549-007-9768-4 17929165 (Epub 2007 Oct 11) (Pubitemid 352009237)